Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application
Malignant mesothelioma (MM) is a rare and aggressive tumour of the serosal cavities linked to asbestos exposure. Improved detection methods for diagnosing this type of neoplastic disease are essential for an early and reliable diagnosis and treatment. Thus, focus has been placed on finding tumour ma...
Main Authors: | Marco Tomasetti, Lory Santarelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/2/523/ |
Similar Items
-
Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
by: Marco Tomasetti, et al.
Published: (2019-11-01) -
Exposure to asbestos in patients with malignant mesothelioma in Iran
by: Gholamreza Pouryaghoub, et al.
Published: (2014-05-01) -
Non-occupational exposure to asbestos is the main cause of malignant mesothelioma in women in North Jutland, Denmark
by: Vasiliki Panou, et al.
Published: (2019-01-01) -
Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on
by: Caterina Ledda, et al.
Published: (2018-06-01) -
Malignant mesothelioma and asbestos exposure in Europe: Evidence of spatial clustering
by: Ewa Wilk, et al.
Published: (2021-05-01)